Physician profile
Michael Nosov
NPI 1023261682
$497.01
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.00 · 2020: $89.29 · 2021: $172 · 2023: $178 · 2024: $34.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $150 · Food and Beverage: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $150.00 |
| Food and Beverage | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $248.00 | 2019-2021 | |
| Zimvie INC. | $150.00 | 2023 | |
| Biohorizons Implant Systems INC. | $28.60 | 2020-2024 | Biohorizons |
| Voco America INC. | $28.13 | 2023 | Rebilda Dc, Futurabond U, Meron Plus Qm |
| Kerr Corporation | $22.22 | 2021 | |
| Solventum Corporation | $20.06 | 2024 | 3m Scotchbond, Clarity Aligners, Relyx Unicem Aplicap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nosov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.